In HNSCC, COX5B was reported as a potent tumor-suppressive gene, whereas in almost all other cancer types, this protein exhibited a growth-promoting property, and its higher levels were correlated with unfavorable clinical outcomes. The gene discussed is COX5B; the disease is neoplasm.